Alpha DNA Investment Management’s Royce Value Trust RVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-24,400
Closed -$337K 214
2023
Q2
$337K Hold
24,400
0.11% 139
2023
Q1
$331K Hold
24,400
0.1% 138
2022
Q4
$324K Buy
+24,400
New +$336K 0.11% 143

Other funds holding RVT

Alpha DNA Investment Management's RVT Position: Q3 2023 in Review

Alpha DNA Investment Management sold out of Royce Value Trust (RVT) in Q3 2023, closing a stake of 24,400 shares — an estimated $337K sold.

Alpha DNA Investment Management first reported a position in RVT in Q4 2022 and held it in 3 quarters. The position peaked at $337K in Q2 2023. 161 funds tracked by Wall St. Rank hold RVT as of Q3 2023.

  • Alpha DNA Investment Management reported no remaining Royce Value Trust position as of Q3 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 24,400 Royce Value Trust shares in Q3 2023, an estimated $337K.
  • Alpha DNA Investment Management first reported a position in Royce Value Trust in Q4 2022 and held it in 3 quarters.
  • Alpha DNA Investment Management's Royce Value Trust position peaked at $337K in Q2 2023.
  • 161 funds tracked by Wall St. Rank held Royce Value Trust as of Q3 2023.

Based on Alpha DNA Investment Management's 13F filing for Q3 2023, filed 7 Nov 2023.